[1]王浩,周则卫,周晓靓.N-(5-硝基吲唑-3-甲酰)酪氨酸钠的制备、乏氧增敏与体内分布研究[J].国际放射医学核医学杂志,2015,39(3):235-238.[doi:10.3760/cma.j.issn.1673-4114.2015.03.010]
 Wang Hao,Zhou Zewei,Zhou Xiaoliang.Synthesis, hypoxic radiosensitization and biodistribution of N-(5-nitroindazole-3-formyl) tyrosine sodium[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):235-238.[doi:10.3760/cma.j.issn.1673-4114.2015.03.010]
点击复制

N-(5-硝基吲唑-3-甲酰)酪氨酸钠的制备、乏氧增敏与体内分布研究(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
39
期数:
2015年第3期
页码:
235-238
栏目:
出版日期:
2015-05-25

文章信息/Info

Title:
Synthesis, hypoxic radiosensitization and biodistribution of N-(5-nitroindazole-3-formyl) tyrosine sodium
作者:
王浩 周则卫 周晓靓
中国医学科学院放射医学研究所, 天津市放射医学与分子核医学重点实验室, 天津, 300192
Author(s):
Wang Hao Zhou Zewei Zhou Xiaoliang
Tianjin Key laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Tianjin 300192, China
关键词:
N-(5-硝基吲唑-3-甲酰)酪氨酸钠肿瘤乏氧增敏体内分布
Keywords:
N-(5-nitroindazole-3-formyl)tyrosine sodiumNeoplasmshypoxic radiosensitizationbiodistribution
DOI:
10.3760/cma.j.issn.1673-4114.2015.03.010
摘要:
目的 在硝基吲唑母核上引入酪氨酸并成盐,制备N-(5-硝基吲唑-3-甲酰)酪氨酸钠并考察其乏氧增敏活性和体内分布情况。方法 用缩合剂法合成N-(5-硝基吲唑-3-甲酰)酪氨酸钠,通过小鼠移植瘤模型评价其乏氧增敏活性,通过放射性碘标记法考察其在荷瘤小鼠体内的分布情况。结果 合成了目标化合物并对结构进行了确证。移植瘤模型增敏实验表明其对H22移植瘤具有一定的乏氧增敏活性,平均放射增敏比为1.5。体内分布实验中其在肿瘤部位与脑和肌肉部位的分布比值均大于5,表明其具有较好的体内分布特性。结论 N-(5-硝基吲唑-3-甲酰)酪氨酸钠具有良好的乏氧增敏活性和体内分布特性,具有进一步开发价值。
Abstract:
Objective To synthesize N-(5-nitroindazole-3-formyl) tyrosine sodium and investigate its hypoxic radiosensitizing effect and biodistribution.Method Synthesized the target compound (N-(5-nitroindazole-3-formyl) tyrosine sodium) using condensing agents,and investigated its radiosensitization under hypoxia using H22 xenograft models and its biodistribution using radioactive iodine labeling.Results The synthesis and structure of the target compound were confirmed.Xenograft models showed that it had a certain radiosensitizing activity and the mean value of sensitization enhancement ratio was 1.5.Biodistribution experiment revealed that it had a good distribution manner,the distribution ratios of tumor to the nervous system and muscle were both greater than 5.Conclusion N-(5-nitroindazole-3-formyl) tyrosine sodium had good radiosensitizing activity and biodistribution manner,and it was worthy of further study.

参考文献/References:

[1] 刘华文,吴敬波. 放射增敏机制的研究进展[J]. 西南军医, 2009,11(2):250-252.
[2] 章鹤,宋建元,曹建平. 肿瘤放射增敏药物的研究进展[J]. 国际放射医学核医学杂志,2014,38(6):408-411.
[3] 蔡芸,陈志龙,赵芳,等. 硝基咪唑类抗肿瘤放射增敏剂研究进展[J]. 中国新药杂志,2003,12(4):249-253.
[4] 叶娟平,刘韬,戴昆怡,等. 放射增敏剂的临床研究进展[J]. 医药导报,2009,28(7):893-896.
[5] Graziano MJ,Henck JW,Meierhenry EF,et al. Neurotoxicity of misonidazole in rats following intravenous administration[J]. Phar-macol Res,1996,33(6):307-318.
[6] Sharma R. Nitroimidazole radiopharmaceuticals in hypoxia:part Ⅱ cytotoxicity and radiosensitization applications[J]. Curr Radiopharm, 2011, 4(4):379-393.
[7] 李光,赵晶,顾菲,等. 2-硝基咪唑-卟啉-二乙撑三氨四乙酸对小鼠Lewis肺癌的放射增敏效应[J]. 中华放射肿瘤学杂志, 2006,15(3):225-228.
[8] Sano Y, Motomura T, Yamamoto F, et al. 1-(3’-[125I]iodophenyl)-3-methy-2-pyrazolin-5-one:preparation, solution stability, and biodistribution in normal mice[J]. Chem Pharm Bull (Tokyo), 2010, 58(8):1020-1025.
[9] Abd Elhalim SM, Ibrahim IT. Radioiodination of 2, 3-dimethyl-4H-furo [3,2-c]coumarin and biological evaluation in solid tumor bearing mice[J]. Appl Radiat Isot, 2014, 95:153-158.
[10] 刘鉴峰,刘金剑,褚丽萍,等. 125Ⅰ标记聚酰胺-胺及其在小鼠体内的生物分布[J]. 国际放射医学核医学杂志,2013,37(2):65-68.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
 He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
 Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
 Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
 Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
 zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
 Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
 Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
 Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
 Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
 Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]

备注/Memo

备注/Memo:
收稿日期:2015-03-16。
基金项目:国家自然科学基金(项目编号:81301983)
通讯作者:周晓靓,Email:zhouxiaoliang@irm-cams.ac.cn
更新日期/Last Update: 1900-01-01